SCHEMBL26880992

SCHEMBL26880992

CCSc1oc2c(C(C)NC(=O)OC(C)(C)C)cc(C)cc2c(=O)c1C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ TSHR P16473 4/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ PIK3CA P42336 4/20 0.35
▸ LMNA P02545 2/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ AKT2 P31751 1/20 0.35
▸ AKT3 Q9Y243 1/20 0.35
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31316372 1.00 ALDH1A1 (0.38) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL26880996 1.00 ALDH1A1 (0.38) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL26662512 0.90 ALDH1A1 (0.37) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL26662516 0.90 ALDH1A1 (0.37) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL31316444 0.90 ALDH1A1 (0.37) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL30742393 0.89 PIK3CA (0.40) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL26881116 0.89 PIK3CA (0.40) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL26881137 0.84 POLB (0.36) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL30584377 0.84 POLB (0.36) ALDH1A1L3MBTL1POLBATMSMN1; SMN2
SCHEMBL30322546 0.83 PIK3CA (0.40) ALDH1A1L3MBTL1POLBATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117769546-A Allosteric ketene inhibitors of phosphoinositide 3-kinase (PI 3K) for the treatment of disease 佩特拉制药公司 2024-03-26 — — CN disclosed
WO-2023212693-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2023-11-02 — — WO disclosed
Send feedback